Event Partner Content WOMA 2026: Steering the Future of Pharma Strategy The WOMA Forum is not merely a conference. It's a convergence point for decision-makers
Market Access Sponsored The stealth market access strategy that’s quietly making man... There is an under-the-radar market access strategy that some manufacturers have implemented, but many others remain unaware of.
Sales & Marketing Sponsored Stress-testing day one: Designing and preparing for a flawle... The pressure to execute a flawless drug or therapy launch has never been greater and continues to lay the foundation for long-term product success.
Sales & Marketing Beyond the vision: Is a 'cultural undertow' drowning your bi... Biopharma thrives on innovation – pouring billions into R&D to bring transformative therapies to life.
Sales & Marketing Sponsored Upscaling your brand strategy: New ways of planning Traditionally, brand teams have stored plans and important data in static documents like PowerPoint decks or spreadsheets, leading to a variety of version control issues once plans cascaded
Sales & Marketing Sponsored How technology enables more dynamic brand planning How new technologies can bring brand planning and strategy development into the digital age.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
